Cite

HARVARD Citation

    Baig, M. et al. (2021). Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma. Journal of pediatric hematology/oncology. 43 (7), p. . [Online]. 
  
Back to record